New shot at sepsis
How Critical Pressure’s CPL001 could stabilize septic shock patients
Critical Pressure Ltd. is developing a therapy for septic shock to combat hypotension more effectively than marketed vasopressors, and without their side effects.
Sepsis is a systemic inflammatory response triggered by severe bacterial infection. Over 30% of patients with sepsis develop septic shock, which is characterized by severe hypotension that can lead to tissue damage, multiple organ failure and death.
Vasopressors, particularly those based on endogenous vasoconstrictors like norepinephrine, are used